Publisher： Adis International
ISSN： 1173-5503
Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.314, 2001-01, pp. : 10-10
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Linezolid: some advantages over vancomycin in MRS
Inpharma, Vol. 1, Iss. 1289, 2001-01 ,pp. :
Access to resources
Recommend
Dalbavancin equivalent to linezolid, cefazolin, vancomycin for SSTI
Inpharma, Vol. 1, Iss. 1451, 2004-01 ,pp. :
IV vancomycin to oral linezolid switch potentially cost saving
Inpharma, Vol. 1, Iss. 1400, 2003-01 ,pp. :
IV vancomycin to oral linezolid switch potentially cost saving
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 425, 2003-01 ,pp. :